• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION EASYTRAK 2 IS-1; IMPLANTABLE LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION EASYTRAK 2 IS-1; IMPLANTABLE LEAD Back to Search Results
Model Number 4543
Medical Device Problem Code Device Dislodged or Dislocated (2923)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/08/2026
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that the left ventricular (lv) lead was misplaced.The lv lead was explanted, and a new lead of a different model was successfully implanted.No additional adverse patient effects were reported.
 
Additional Manufacturer Narrative
This report is being submitted to correct the bsc aware date field (g3) in section g, all manufacturers.
 
Event or Problem Description
It was reported that the left ventricular (lv) lead was misplaced.The lv lead was explanted, and a new lead of a different model was successfully implanted.No additional adverse patient effects were reported.Additional information received which indicates that during this procedure, the patient had a contrast allergy and visualization of the actual placement was not possible that time.Furthermore, a lead dislodgement was then suspected.
 
Event or Problem Description
It was reported that the left ventricular (lv) lead was misplaced.The lv lead was explanted, and a new lead of a different model was successfully implanted.No additional adverse patient effects were reported.Additional information received which indicates that during this procedure, the patient had a contrast allergy and visualization of the actual placement was not possible that time.Furthermore, a lead dislodgement was then suspected.
 
Additional Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, visual inspection of the lead was performed.Visual inspection revealed no abnormalities.Laboratory testing did not identify any lead characteristics that would have resulted in the clinical observation of dislodgement.No lead issues were noted that would have made dislodgement more likely than what is described in the instructions for use as a known inherent risk of the use of this product.A review of the device history record (dhr) was performed.The review of the dhr identified that there were no process related non-conformances, scrap, or rework performed during the production that could explain the event.The reviews ensure each device meets specification prior to release for use.There is no indication the device manufacturing process contributed to the reported complaint.A risk review was completed and confirmed that the event of dislodged or dislocated was defined in the risk documentation.This event type has been accounted for during product risk analysis to support acceptable risk benefit for the product.Review of labeling determined that the complaint situation was listed in the manual.There was no indication in the complaint that the product was not used in accordance to labeling.The manual was unlikely to be the cause of the reported complaint; translation, wording, or graphics does not require further review.Based on a thorough review of the reported complaint, boston scientific has assigned an investigation conclusion code of known inherent risk.This report is being submitted to correct the bsc aware date field (g3) in section g, all manufacturers.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EASYTRAK 2 IS-1
Common Device Name
IMPLANTABLE LEAD
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
road 698, lot no. 12
dorado PR 00646 -260
*   00646-2602
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key24389227
Report Number2124215-2026-09302
Device Sequence Number16107678
Product Code NIK
UDI-Device Identifier00802526410994
UDI-Public(01)00802526410994(17)141126
Combination Product (Y/N)Y
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
P010012
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2012
Device Explanted Year2026
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,User Facility,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 06/24/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date11/26/2014
Device Model Number4543
Device Catalogue Number4543
Device Lot Number177929
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/26/2026
Supplement Date Received by Manufacturer01/08/2026
06/05/2026
Initial Report FDA Received Date02/19/2026
Supplement Report FDA Received Date03/24/2026
06/24/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured11/26/2012
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age63 YR
Patient SexFemale
-
-